4.7 Article

Exploring regulation and function of dopamine D3 receptors in alcohol use disorder. A PET [11C]-(+)-PHNO study

期刊

NEUROPSYCHOPHARMACOLOGY
卷 46, 期 12, 页码 2112-2120

出版社

SPRINGERNATURE
DOI: 10.1038/s41386-021-01095-2

关键词

-

资金

  1. National Institute on Alcohol Abuse and Alcoholism (NIAAA) [1R21AA023967-01A1]
  2. Pfizer
  3. Canopy
  4. Bioprojet, ACS
  5. Alkermes
  6. CIHR
  7. NIH
  8. CAMH
  9. department of Family and Community Medicine of the University of Toronto
  10. NIH (Indiana Alcohol Research Centre, Indiana University) [P60 AA007611]

向作者/读者索取更多资源

Preclinical studies suggest a role of DRD3 receptors in AUD, but this study found lower levels of DRD2/3 binding in AUD subjects compared to healthy controls. Despite no specific regional differences, there were reductions in binding levels in certain areas, and a positive association between binding in the SN and alcohol demand. Further research is needed to explore the implications of these findings.
Preclinical studies support an important role of dopamine D3 receptors (DRD3s) in alcohol use disorder (AUD). In animals, voluntary alcohol consumption increases DRD3 expression, and pharmacological blockade of DRD3s attenuates alcohol self-administration and reinstatement of alcohol seeking. However, these findings have yet to be translated in humans. This study used positron emission tomography (PET) and [C-11]-(+)-PHNO to compare receptor levels in several dopamine D2 receptor (DRD2) and DRD3 regions of interest between AUD subjects in early abstinence (n = 17; 6.59 +/- 4.14 days of abstinence) and healthy controls (n = 18). We recruited non-treatment seeking subjects meeting DSM-5 criteria for AUD. We examined the relationship between DRD2/3 levels and both alcohol craving and alcohol motivation/wanting, using a cue reactivity procedure and an intravenous alcohol self-administration (IVASA) paradigm, respectively. [C-11]-(+)-PHNO binding levels in AUD subjects were significantly lower than binding in HCs when looking at all DRD2/3 ROIs jointly (Wilk's Lambda = .58, F(6,28) =3.33, p = 0.013, eta(2)(p) = 0.42), however there were no region-specific differences. Binding values demonstrate -12.3% and -16.1% lower [C-11]-(+)-PHNO binding in the SMST and SN respectively, though these differences did not withstand Bonferroni corrections. There was a positive association between [C-11]-(+)-PHNO binding in the SN (almost exclusively reflective of DRD3) and alpha (lower values reflect higher alcohol demand) in the APT after Bonferroni corrections (r = 0.66, p = 0.0080). This demonstrates that AUD subjects with lower DRD3 levels in the SN exhibit increased demand for alcohol. These results replicate previous findings demonstrating reduced DRD2/3 levels while also supporting a lack of DRD3 upregulation and potential downregulation in early abstinent AUD. Furthermore, the finding that binding in the SN is associated with alcohol demand warrants further examination.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据